Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Apr 02, 2019 2:46pm
74 Views
Post# 29571665

RE:RE:RE:'ANTICIPATION" from a Ceapro Private Placement Prospectus.

RE:RE:RE:'ANTICIPATION" from a Ceapro Private Placement Prospectus.Management didn't value the company at 1.06, the market did at one point in time (when the company was very profitable, growing, potential new revenue streams etc).  

Agree that management was likely restricted in selling (not to mention how ridiculous it would be to pump the share price before a private placement then shortly after management sells their shares).

PGX most definately was widely known and promoted at the time.  At that time it had more promise as one could believe that other companies were actually interested in the technology.  Now they've had years to make a deal and so far no takers.

I don't know many of CZO's presentations from that time period are still available, but they were making it known that PGX would be the future of the company.  Look at the Crystal Research report that CZO paid for from 2016, "PGX" is mentioned 145 times lol.

The valuation of the company with (or without) PGX is nowhere near 1.06 (see the current share price).  The company used to actually make money and was growing revenue (with the potential of even greater revenue with the new capacity of the new plant).  Now it's the exact opposite and the share price is reflecting current day reality rather than expectations of what today would be like from a few years ago.

trek01 wrote: Im glad someone brought up the private placement. The management basically valued the company at 1.06 at that time. The stock went up to well over 2. If someone is telling here all the time that mgmt didn't sell at that point, that I'd quite confidently say that they just couldn't sell because of their vesting periods. However at that time they seem to not really understand what is the pxg capable of doing and didn't really give much effort to explore it. They wert more focused on expanding the sales of the cosmetics and the new plant. I believe the valuation without the pgx is around the last private placement value. The company now seems to be focusing on pgx and it should be the driver for future. When sp meets the valuation is the question given the stupid exchange and a lot of retail money in pot stocks.


Bullboard Posts